JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chinni, C.
Right arrow Articles by Mackie, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinni, C.
Right arrow Articles by Mackie, E. J.

J Biol Chem, Vol. 274, Issue 14, 9169-9174, April 2, 1999

Thrombin, a Survival Factor for Cultured Myoblasts

Carla ChinniDagger , Michael R. de NieseDagger , Deborah J. TewDagger , Alison L. JenkinsDagger , Stephen P. BottomleyDagger , and Eleanor J. Mackie

From the Dagger  Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3168, Australia and the  School of Veterinary Science, University of Melbourne, Parkville, Victoria 3052, Australia

Three members of the family of protease-activated receptors (PARs), PARs-1, -3 and -4, have been identified as thrombin receptors. PAR-1 is expressed by primary myoblast cultures, and expression is repressed once myoblasts fuse to form myotubes. The current study was undertaken to investigate the hypothesis that thrombin inhibits myoblast fusion. Primary rodent myoblast cultures were deprived of serum to promote myoblast fusion and then cultured in the presence or absence of thrombin. Thrombin inhibited myoblast fusion, but another notable effect was observed; 50% of control cells were apoptotic within 24 h of serum deprivation, whereas less than 15% of thrombin-treated cells showed signs of apoptosis. Proteolysis was required for the effect of thrombin, but no other serine protease tested mimicked the action of thrombin. Neither a PAR-1- nor a PAR-4-activating peptide inhibited apoptosis or fusion, and myoblast cultures were negative for PAR-3 expression. Myoblasts exposed to thrombin for 1 h and then changed to medium without thrombin accumulated apoptosis inhibitory activity in their medium over the subsequent 20 h. Thus the protective action of thrombin appears to be effected through cleavage of an unidentified thrombin receptor, leading to secretion of a downstream apoptosis inhibitory factor. These results demonstrate that thrombin functions as a survival factor for myoblasts and is likely to play an important role in muscle development and repair.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Sheffler, W. K. Kroeze, B. G. Garcia, A. Y. Deutch, S. J. Hufeisen, P. Leahy, J. C. Bruning, and B. L. Roth
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling
PNAS, March 21, 2006; 103(12): 4717 - 4722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. J. Song, C. N. Pagel, T. M. Campbell, R. N. Pike, and E. J. Mackie
The Role of Protease-Activated Receptor-1 in Bone Healing
Am. J. Pathol., March 1, 2005; 166(3): 857 - 868.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird
Thrombin and Phenotypic Modulation of the Endothelium
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 41 - 53.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. G. Mann
Thrombin: Can't Live Without It; Probably Die From It
Chest, September 1, 2003; 124(3_suppl): 1S - 3S.
[Full Text] [PDF]


Home page
BloodHome page
B. B. Sorensen, L. V. M. Rao, D. Tornehave, S. Gammeltoft, and L. C. Petersen
Antiapoptotic effect of coagulation factor VIIa
Blood, September 1, 2003; 102(5): 1708 - 1715.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. M. van den Eijnde, M. J. B. van den Hoff, C. P. M. Reutelingsperger, W. L. van Heerde, M. E. R. Henfling, C. Vermeij-Keers, B. Schutte, M. Borgers, and F. C. S. Ramaekers
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation
J. Cell Sci., March 12, 2002; 114(20): 3631 - 3642.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Shefer, T. A. Partridge, L. Heslop, J. G. Gross, U. Oron, and O. Halevy
Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells
J. Cell Sci., January 4, 2002; 115(7): 1461 - 1469.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C Chinni, M. de Niese, A. Jenkins, R. Pike, S. Bottomley, and E. Mackie
Protease-activated receptor-2 mediates proliferative responses in skeletal myoblasts
J. Cell Sci., January 12, 2000; 113(24): 4427 - 4433.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. Ryu, H. Pyo, I. Jou, and E. Joe
Thrombin Induces NO Release from Cultured Rat Microglia via Protein Kinase C, Mitogen-activated Protein Kinase, and NF-kappa B
J. Biol. Chem., September 22, 2000; 275(39): 29955 - 29959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.